“There’s never really been a case challenging the FDA approval of a drug in this way, when the science is so clear and it’s been on the market for so long and it’s so clearly safe,” said Cat Duffy, a policy analyst at the National Health Law Program, which works to protect abortion access.
***
Before becoming a judge, Kacsmaryk worked as deputy general counsel at the First Liberty Institute, a nonprofit Christian conservative legal organization. In 2015, he published articles criticizing abortion rights and same-sex marriage.
***
“In front of another judge, this case would have never seen the light of day and would have been dismissed on procedural grounds,” Duffy said.
***
Read more at NBC News